Net income: CA$2.60m (up 40% from 2Q 2024). Profit margin: 3.2% (up from 2.9% in 2Q 2024). EPS: CA$0.05 (up from CA$0.048 in ...

Aurora Cannabis sees 29% YoY growth and solid cash flow, unaffected by U.S. market fears. Read why ACB stock remains a solid ...

Shares of Aurora Cannabis Inc. ACB slid 1.05% to $4.73 Tuesday, on what proved to be an all-around grim trading session for the stock market, with the NASDAQ Composite Index COMP falling 0.09% to ...

Aurora Cannabis (US) ( (ACB) ) has released its Q2 earnings. Here is a breakdown of the information Aurora Cannabis (US) presented to its ...

Q2 2025 Earnings Call Transcript November 6, 2024 Operator: Greetings and welcome to the Aurora Cannabis Inc. Second Quarter 2025 Results Conference Call. all participants will be in a listen-only ...

Aurora's international medical cannabis business bolstered its results, with European sales doubling quarter-over-quarter.

We will discontinue analyst coverage of Aurora Cannabis on or about Nov. 29. We provide analyst research and ratings on over 1,500 companies globally and periodically adjust our coverage according ...

Working capital for the three months ended September 30, 2023 has been adjusted. Refer to discussion under "Liquidity and Capital Resources" section of the MD&A. View ...

View Aurora Cannabis Inc. (ACB) current and estimated P/E ratio data provided by Seeking Alpha.

Its third quarter results are in the books and Beacon Securities analyst Doug Cooper still thinks there is money to be made ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...